Current and historical daily PE Ratio for Ligand Pharmaceuticals Inc (
STU:LGDN
) from 2013 to Sep 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Ligand Pharmaceuticals stock (STU:LGDN) PE ratio as of Sep 21 2024 is 44.58.
More Details
Ligand Pharmaceuticals Inc (STU:LGDN) PE Ratio (TTM) Chart
Ligand Pharmaceuticals Inc (STU:LGDN) PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Total 1282
- 1
- 2
- 3
- 4
- 5
- 6
- 15
Ligand Pharmaceuticals PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-09-21 | 43.9 | 2024-07-22 | 44.3 |
2024-09-20 | 43.9 | 2024-07-19 | 43.6 |
2024-09-19 | 44.8 | 2024-07-18 | 43.6 |
2024-09-18 | 44.6 | 2024-07-17 | 43.6 |
2024-09-17 | 44.1 | 2024-07-16 | 43.6 |
2024-09-16 | 45.3 | 2024-07-15 | 42.2 |
2024-09-13 | 45.3 | 2024-07-12 | 43.9 |
2024-09-12 | 44.6 | 2024-07-11 | 43.1 |
2024-09-11 | 44.8 | 2024-07-10 | 42.2 |
2024-09-10 | 44.6 | 2024-07-09 | 38.4 |
2024-09-09 | 44.6 | 2024-07-08 | 38.6 |
2024-09-06 | 43.1 | 2024-07-05 | 36.0 |
2024-09-05 | 44.3 | 2024-07-04 | 36.9 |
2024-09-04 | 43.9 | 2024-07-03 | 37.1 |
2024-09-03 | 45.8 | 2024-07-02 | 37.6 |
2024-09-02 | 45.8 | 2024-07-01 | 37.9 |
2024-08-30 | 46.0 | 2024-06-28 | 36.2 |
2024-08-29 | 45.1 | 2024-06-27 | 15.3 |
2024-08-28 | 45.8 | 2024-06-26 | 14.9 |
2024-08-27 | 45.3 | 2024-06-25 | 15.3 |
2024-08-26 | 44.8 | 2024-06-24 | 15.2 |
2024-08-23 | 43.9 | 2024-06-21 | 15.2 |
2024-08-22 | 43.9 | 2024-06-20 | 15.2 |
2024-08-21 | 45.5 | 2024-06-19 | 15.4 |
2024-08-20 | 44.8 | 2024-06-18 | 15.4 |
2024-08-19 | 44.3 | 2024-06-17 | 14.8 |
2024-08-16 | 45.1 | 2024-06-14 | 15.5 |
2024-08-15 | 45.8 | 2024-06-13 | 15.3 |
2024-08-14 | 43.9 | 2024-06-12 | 15.3 |
2024-08-13 | 43.9 | 2024-06-11 | 15.3 |
2024-08-12 | 43.9 | 2024-06-10 | 15.1 |
2024-08-09 | 42.4 | 2024-06-07 | 15.2 |
2024-08-08 | 40.8 | 2024-06-06 | 15.4 |
2024-08-07 | 43.1 | 2024-06-05 | 15.3 |
2024-08-06 | 43.6 | 2024-06-04 | 16.4 |
2024-08-05 | 42.2 | 2024-06-03 | 16.1 |
2024-08-02 | 43.4 | 2024-05-31 | 16.3 |
2024-08-01 | 48.4 | 2024-05-30 | 16.0 |
2024-07-31 | 48.4 | 2024-05-29 | 16.0 |
2024-07-30 | 48.4 | 2024-05-28 | 16.0 |
2024-07-29 | 46.0 | 2024-05-27 | 16.3 |
2024-07-26 | 46.7 | 2024-05-24 | 16.0 |
2024-07-25 | 46.7 | 2024-05-23 | 16.0 |
2024-07-24 | 45.5 | 2024-05-22 | 16.4 |
2024-07-23 | 43.1 | 2024-05-21 | 16.3 |
Ligand Pharmaceuticals Inc (STU:LGDN) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Ligand Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US53220K5048
Description